Why Maximus is Back on Investors’ Radar
Maximus (MMS) drew fresh attention after reporting a 5.1% year-on-year revenue decline to US$1.28b, missing analyst expectations and pairing that shortfall with softer full-year EPS guidance.
The mixed quarter has played out in the chart too. Maximus shares have rallied with a 19.8% 1 month share price return after the earnings release, yet the year to date share price return is still down 27.1% and the 1 year total shareholder return has fallen 25.5%. This points to short term momentum trying to repair a weaker longer term record.
Compare Maximus’s mixed quarter with a curated group of government and service providers that are showing stronger momentum by using our 28 high quality undervalued stocks to explore potential alternatives with healthier fundamentals.
The sharp 1 month rebound in Maximus after a weaker year to date record puts you at a fork in the road. Is this an early reset worth accepting, or does patience for a better entry make more sense as valuation comes into focus?
Most Popular Narrative: 32% Undervalued
On the most followed view of Maximus, a fair value of $92.50 sits well above the last close at $63.02. This puts the recent share rebound against a still sizeable valuation gap built on specific growth drivers rather than just sentiment.
AI enabled automation is now embedded in the majority of Maximus bidding activity, with around 75% to 80% of new bids and rebids containing explicit AI requirements and early deployments on five contracts contributing around a 3.5 percentage point operating margin uplift. This points to further opportunity for revenue winning differentiation and higher margins as this model scales.
See why 5 investors see Maximus as 32% undervalued.
Result: Fair Value of $92.50 (UNDERVALUED)
Still, the thesis around Maximus only holds if the VA incentive pause does not drag on and if low margin international operations stop diluting profitability.
Find out about the key risks to this Maximus narrative.
Next Steps
Mixed signals on Maximus can pull you in both directions, so act while the data is fresh and pressure test the bullish and cautious arguments yourself by walking through the 5 key rewards and 1 important warning sign.
Looking for more Maximus-sized investment ideas?
If Maximus has you thinking harder about where to put fresh capital, do not stop at one ticker. Use the Simply Wall Street Screener to compare, filter, and uncover ideas that actually fit your playbook instead of settling for whatever is already on your watchlist.
- Target resilient balance sheets by scanning a list of solid balance sheet and fundamentals (24 results) that can handle tougher conditions without constant fundraising risk.
- Hunt for mispriced quality using our 21 high quality undiscovered gems that surfaces underfollowed businesses with fundamentals that already stack up.
- Dial down portfolio stress by focusing on a 30 resilient stocks with low risk scores that screens for companies with stronger financial health and fewer red flags.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com